The association between MET (MET Proto-Oncogene, Receptor Tyrosine Kinase) and Inherited Cancer-Predisposing Syndrome is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.
Sources2
Clinical variants2,456
Symptoms0
Compounds0
Trials0
Publications18
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.